RxDoctor Payments Data

Scott Beecher

Optometrist · Sioux City, IANPI 1841282050

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Alcon at 47.3% of the total. Reporting peaked in 2024 at $173 and has fallen 89.2% since, to $19 in 2025.

$750in general payments, 2019–2025

Across 20 payments — averaging $37.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$354
  • Johnson & Johnson Vision Care, Inc.$168
  • Topcon Healthcare, Inc.$89
  • Sun Pharmaceutical Industries Inc.$74
  • Coopervision Inc.$65

What the payments were for

  • Food & beverage$750100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$750 in reported general payments places this provider in the 60th percentile of 559 optometrist providers in Iowa.

See all optometrist providers in Iowa

Medicare billing

Part B allowed, 2024
$113,186
Medicare patients
587
Services billed
1,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost115$1,364
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha43$374
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat18$336
Timolol Maleate27$251
Dorzolamide Hcl12$181

Paid to pharmacies, not to this prescriber.

Other optometrist in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →